 Steven Edmundowicz
Concepts (469)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endoscopy, Gastrointestinal | 29 | 2023 | 202 | 4.150 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 35 | 2024 | 176 | 3.740 |
Why?
| | Endosonography | 29 | 2023 | 142 | 2.320 |
Why?
| | Bariatric Surgery | 12 | 2019 | 166 | 2.190 |
Why?
| | Esophageal Neoplasms | 13 | 2022 | 281 | 2.010 |
Why?
| | Pancreatic Neoplasms | 20 | 2023 | 734 | 1.970 |
Why?
| | Endoscopy, Digestive System | 16 | 2021 | 111 | 1.970 |
Why?
| | Adenoma | 12 | 2023 | 191 | 1.710 |
Why?
| | Endoscopy | 13 | 2020 | 272 | 1.680 |
Why?
| | Weight Loss | 11 | 2019 | 655 | 1.620 |
Why?
| | Gastric Balloon | 6 | 2018 | 13 | 1.530 |
Why?
| | Obesity | 17 | 2019 | 2746 | 1.500 |
Why?
| | Gastroplasty | 5 | 2019 | 26 | 1.430 |
Why?
| | Adenocarcinoma | 13 | 2023 | 812 | 1.310 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2019 | 109 | 1.300 |
Why?
| | Stomach Neoplasms | 5 | 2020 | 67 | 1.230 |
Why?
| | Barrett Esophagus | 10 | 2022 | 154 | 1.210 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 9 | 2019 | 52 | 1.160 |
Why?
| | Colonic Neoplasms | 6 | 2015 | 224 | 1.150 |
Why?
| | Drainage | 11 | 2023 | 157 | 1.080 |
Why?
| | Gastroenterology | 10 | 2019 | 158 | 1.060 |
Why?
| | Colonic Polyps | 7 | 2015 | 70 | 1.060 |
Why?
| | Colonoscopy | 12 | 2023 | 208 | 1.050 |
Why?
| | Gastroesophageal Reflux | 11 | 2020 | 248 | 0.960 |
Why?
| | Bile Duct Neoplasms | 4 | 2020 | 55 | 0.960 |
Why?
| | Pancreatitis | 11 | 2024 | 108 | 0.880 |
Why?
| | Stents | 16 | 2024 | 457 | 0.870 |
Why?
| | Gastrointestinal Diseases | 4 | 2022 | 187 | 0.810 |
Why?
| | Pancreatic Ducts | 8 | 2022 | 66 | 0.810 |
Why?
| | Cholestasis | 3 | 2020 | 228 | 0.800 |
Why?
| | Duodenoscopes | 2 | 2020 | 7 | 0.770 |
Why?
| | Duodenum | 4 | 2019 | 67 | 0.770 |
Why?
| | Obesity, Morbid | 7 | 2019 | 197 | 0.760 |
Why?
| | Esophagus | 8 | 2019 | 237 | 0.740 |
Why?
| | Pancreatic Diseases | 6 | 2023 | 63 | 0.720 |
Why?
| | Humans | 156 | 2024 | 118974 | 0.720 |
Why?
| | Biliary Tract Neoplasms | 1 | 2019 | 20 | 0.720 |
Why?
| | Middle Aged | 88 | 2022 | 27617 | 0.710 |
Why?
| | Biopsy, Fine-Needle | 8 | 2017 | 69 | 0.690 |
Why?
| | Clinical Competence | 11 | 2020 | 951 | 0.690 |
Why?
| | Pancreatic Pseudocyst | 4 | 2018 | 13 | 0.660 |
Why?
| | Aged | 67 | 2022 | 19657 | 0.630 |
Why?
| | Cross Infection | 1 | 2020 | 205 | 0.630 |
Why?
| | Gastrostomy | 5 | 2019 | 93 | 0.620 |
Why?
| | Learning Curve | 6 | 2019 | 67 | 0.610 |
Why?
| | Radiation Exposure | 1 | 2017 | 44 | 0.610 |
Why?
| | Endoscopic Mucosal Resection | 5 | 2022 | 26 | 0.610 |
Why?
| | Intestine, Small | 2 | 2020 | 131 | 0.600 |
Why?
| | Colonic Diseases | 3 | 2013 | 26 | 0.580 |
Why?
| | Prospective Studies | 35 | 2023 | 6471 | 0.580 |
Why?
| | Radiation Injuries | 1 | 2017 | 131 | 0.570 |
Why?
| | Jejunum | 2 | 2015 | 30 | 0.570 |
Why?
| | Self Expandable Metallic Stents | 3 | 2022 | 14 | 0.540 |
Why?
| | Smell | 1 | 2016 | 118 | 0.540 |
Why?
| | Pathology, Clinical | 1 | 2015 | 31 | 0.530 |
Why?
| | Treatment Outcome | 34 | 2023 | 9342 | 0.530 |
Why?
| | Gastrointestinal Neoplasms | 2 | 2013 | 61 | 0.530 |
Why?
| | Pancreas | 7 | 2021 | 282 | 0.530 |
Why?
| | Pancreatitis, Chronic | 4 | 2022 | 39 | 0.520 |
Why?
| | Cholelithiasis | 8 | 2010 | 30 | 0.520 |
Why?
| | Male | 89 | 2023 | 57801 | 0.520 |
Why?
| | Laparoscopy | 6 | 2020 | 417 | 0.520 |
Why?
| | Female | 91 | 2023 | 61565 | 0.500 |
Why?
| | Suction | 2 | 2017 | 32 | 0.500 |
Why?
| | Catheter Ablation | 5 | 2022 | 286 | 0.500 |
Why?
| | Postoperative Hemorrhage | 3 | 2017 | 79 | 0.480 |
Why?
| | Esophagoscopy | 8 | 2022 | 190 | 0.470 |
Why?
| | Gallstones | 6 | 1996 | 26 | 0.470 |
Why?
| | Lithotripsy | 5 | 2019 | 37 | 0.460 |
Why?
| | Catheterization | 8 | 2019 | 163 | 0.440 |
Why?
| | Adult | 58 | 2024 | 31512 | 0.440 |
Why?
| | Propofol | 4 | 2023 | 49 | 0.440 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2017 | 2174 | 0.430 |
Why?
| | Sensitivity and Specificity | 11 | 2019 | 1795 | 0.430 |
Why?
| | Colorectal Neoplasms | 5 | 2022 | 628 | 0.420 |
Why?
| | Body Weight | 1 | 2016 | 934 | 0.420 |
Why?
| | Gastroscopy | 4 | 2014 | 17 | 0.400 |
Why?
| | Precancerous Conditions | 4 | 2017 | 160 | 0.400 |
Why?
| | Biopsy | 5 | 2019 | 1079 | 0.400 |
Why?
| | Aged, 80 and over | 22 | 2019 | 6561 | 0.380 |
Why?
| | Quality Indicators, Health Care | 5 | 2018 | 295 | 0.380 |
Why?
| | Indomethacin | 2 | 2024 | 75 | 0.380 |
Why?
| | Bile Ducts | 5 | 2014 | 73 | 0.380 |
Why?
| | Postoperative Complications | 10 | 2021 | 2235 | 0.370 |
Why?
| | Duodenal Neoplasms | 2 | 2023 | 18 | 0.370 |
Why?
| | Ampulla of Vater | 3 | 2023 | 28 | 0.370 |
Why?
| | Pancreatic Cyst | 3 | 2018 | 47 | 0.370 |
Why?
| | Cytodiagnosis | 2 | 2020 | 27 | 0.360 |
Why?
| | Pancreatitis, Acute Necrotizing | 3 | 2023 | 11 | 0.360 |
Why?
| | Insufflation | 1 | 2009 | 9 | 0.350 |
Why?
| | Constriction, Pathologic | 6 | 2022 | 203 | 0.350 |
Why?
| | Common Bile Duct Neoplasms | 2 | 2023 | 23 | 0.340 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2020 | 310 | 0.330 |
Why?
| | Esophagogastric Junction | 3 | 2019 | 41 | 0.330 |
Why?
| | Cholecystectomy, Laparoscopic | 6 | 2008 | 44 | 0.330 |
Why?
| | Retrospective Studies | 34 | 2023 | 12978 | 0.330 |
Why?
| | Calculi | 3 | 2019 | 14 | 0.310 |
Why?
| | Pain, Postoperative | 1 | 2009 | 211 | 0.300 |
Why?
| | Carbon Dioxide | 1 | 2009 | 230 | 0.300 |
Why?
| | Decompression, Surgical | 2 | 2023 | 97 | 0.300 |
Why?
| | Pancreatectomy | 2 | 2021 | 165 | 0.290 |
Why?
| | Sphincterotomy, Endoscopic | 6 | 2019 | 24 | 0.290 |
Why?
| | Gastrointestinal Stromal Tumors | 3 | 2015 | 43 | 0.290 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 141 | 0.290 |
Why?
| | Body Mass Index | 7 | 2019 | 2092 | 0.290 |
Why?
| | Neoplasm Recurrence, Local | 4 | 2023 | 900 | 0.280 |
Why?
| | Endoscopes, Gastrointestinal | 1 | 2006 | 12 | 0.280 |
Why?
| | Follow-Up Studies | 16 | 2015 | 4596 | 0.280 |
Why?
| | Thoracoscopy | 1 | 2006 | 58 | 0.270 |
Why?
| | Neuroendocrine Tumors | 2 | 2018 | 83 | 0.270 |
Why?
| | Early Detection of Cancer | 5 | 2022 | 360 | 0.260 |
Why?
| | Mental Recall | 1 | 2006 | 180 | 0.260 |
Why?
| | Societies, Medical | 3 | 2018 | 703 | 0.250 |
Why?
| | Esophageal Sphincter, Lower | 2 | 2015 | 10 | 0.250 |
Why?
| | Polyvinyls | 1 | 2004 | 17 | 0.250 |
Why?
| | Plastics | 3 | 2022 | 35 | 0.250 |
Why?
| | Magnets | 2 | 2015 | 15 | 0.250 |
Why?
| | Gastric Bypass | 2 | 2017 | 93 | 0.240 |
Why?
| | Periodicals as Topic | 1 | 2006 | 191 | 0.230 |
Why?
| | Ablation Techniques | 3 | 2017 | 29 | 0.230 |
Why?
| | Common Bile Duct | 3 | 2009 | 14 | 0.220 |
Why?
| | Internet | 2 | 2009 | 633 | 0.220 |
Why?
| | Patient Satisfaction | 1 | 2006 | 610 | 0.220 |
Why?
| | Fluoroscopy | 3 | 2019 | 146 | 0.210 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2017 | 210 | 0.210 |
Why?
| | Anesthesia | 1 | 2023 | 120 | 0.210 |
Why?
| | Prostheses and Implants | 3 | 2013 | 141 | 0.210 |
Why?
| | Pneumonia, Aspiration | 2 | 2019 | 16 | 0.210 |
Why?
| | Deglutition Disorders | 3 | 2019 | 131 | 0.200 |
Why?
| | Intestinal Perforation | 2 | 2018 | 41 | 0.200 |
Why?
| | Prosthesis Design | 3 | 2019 | 285 | 0.190 |
Why?
| | Carcinoembryonic Antigen | 3 | 2018 | 36 | 0.190 |
Why?
| | Double-Blind Method | 7 | 2018 | 1687 | 0.190 |
Why?
| | Quality of Life | 10 | 2019 | 2366 | 0.190 |
Why?
| | Varicose Veins | 1 | 2020 | 15 | 0.190 |
Why?
| | Neoplasm Staging | 5 | 2017 | 1223 | 0.180 |
Why?
| | Esophageal and Gastric Varices | 1 | 2020 | 40 | 0.180 |
Why?
| | Biliary Tract Diseases | 4 | 2014 | 35 | 0.180 |
Why?
| | Deep Sedation | 2 | 2010 | 11 | 0.180 |
Why?
| | Abdominal Pain | 3 | 2019 | 133 | 0.180 |
Why?
| | Cell-Free System | 1 | 2019 | 49 | 0.180 |
Why?
| | Equipment Design | 6 | 2020 | 519 | 0.180 |
Why?
| | Liver Neoplasms | 1 | 2023 | 527 | 0.180 |
Why?
| | Fiducial Markers | 1 | 2019 | 12 | 0.170 |
Why?
| | Urinary Calculi | 1 | 2019 | 12 | 0.170 |
Why?
| | Watchful Waiting | 3 | 2019 | 55 | 0.170 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2019 | 32 | 0.170 |
Why?
| | Academic Medical Centers | 3 | 2023 | 422 | 0.170 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1440 | 0.170 |
Why?
| | Needles | 1 | 2019 | 56 | 0.170 |
Why?
| | Infection Control | 1 | 2020 | 135 | 0.170 |
Why?
| | Metals | 4 | 2023 | 111 | 0.160 |
Why?
| | Esophageal Stenosis | 1 | 2019 | 47 | 0.160 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2024 | 304 | 0.160 |
Why?
| | Abdomen | 2 | 2016 | 110 | 0.160 |
Why?
| | Reproducibility of Results | 7 | 2020 | 2874 | 0.160 |
Why?
| | Cystadenoma, Serous | 1 | 2018 | 17 | 0.160 |
Why?
| | Simulation Training | 1 | 2019 | 66 | 0.160 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 79 | 0.160 |
Why?
| | Obesity Management | 1 | 2017 | 8 | 0.160 |
Why?
| | Cystadenoma, Mucinous | 2 | 2015 | 12 | 0.160 |
Why?
| | Cystadenocarcinoma, Mucinous | 2 | 2015 | 13 | 0.150 |
Why?
| | Aneurysm, False | 1 | 2018 | 46 | 0.150 |
Why?
| | Conscious Sedation | 2 | 2023 | 79 | 0.150 |
Why?
| | Education, Medical, Graduate | 2 | 2019 | 399 | 0.150 |
Why?
| | Suture Techniques | 3 | 2017 | 134 | 0.150 |
Why?
| | Pancreaticoduodenectomy | 2 | 2016 | 128 | 0.150 |
Why?
| | Diagnostic Tests, Routine | 1 | 2018 | 88 | 0.150 |
Why?
| | Logistic Models | 6 | 2021 | 1901 | 0.150 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2017 | 88 | 0.150 |
Why?
| | Metaplasia | 4 | 2022 | 57 | 0.150 |
Why?
| | Diet Therapy | 1 | 2016 | 38 | 0.150 |
Why?
| | Immunoassay | 1 | 2017 | 101 | 0.140 |
Why?
| | Polymerase Chain Reaction | 1 | 2019 | 1012 | 0.140 |
Why?
| | Referral and Consultation | 3 | 2019 | 648 | 0.140 |
Why?
| | Calcinosis | 1 | 2019 | 282 | 0.140 |
Why?
| | Population Surveillance | 2 | 2017 | 413 | 0.140 |
Why?
| | Stomach | 1 | 2016 | 103 | 0.140 |
Why?
| | Respiratory Insufficiency | 2 | 2010 | 290 | 0.140 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 24 | 0.140 |
Why?
| | Intestinal Mucosa | 3 | 2017 | 531 | 0.140 |
Why?
| | Bariatric Medicine | 1 | 2015 | 2 | 0.140 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 250 | 0.140 |
Why?
| | Pilot Projects | 2 | 2013 | 1419 | 0.130 |
Why?
| | Intubation, Gastrointestinal | 1 | 1996 | 61 | 0.130 |
Why?
| | Single-Blind Method | 5 | 2019 | 269 | 0.130 |
Why?
| | Dogs | 1 | 2016 | 371 | 0.130 |
Why?
| | Life Style | 2 | 2018 | 430 | 0.130 |
Why?
| | Colon, Ascending | 1 | 2015 | 3 | 0.130 |
Why?
| | Documentation | 1 | 2017 | 175 | 0.130 |
Why?
| | Dissection | 1 | 2015 | 55 | 0.130 |
Why?
| | Risk Factors | 11 | 2024 | 9000 | 0.130 |
Why?
| | Cholecystectomy | 4 | 2009 | 45 | 0.130 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2015 | 56 | 0.130 |
Why?
| | Leiomyoma | 1 | 2015 | 45 | 0.130 |
Why?
| | Young Adult | 10 | 2018 | 10793 | 0.130 |
Why?
| | Peristalsis | 2 | 1991 | 30 | 0.130 |
Why?
| | Proton Pump Inhibitors | 3 | 2020 | 98 | 0.120 |
Why?
| | Colorectal Surgery | 1 | 2014 | 22 | 0.120 |
Why?
| | Aptitude | 1 | 2014 | 40 | 0.120 |
Why?
| | Biomarkers, Tumor | 3 | 2017 | 1059 | 0.120 |
Why?
| | Ulcer | 1 | 2014 | 28 | 0.120 |
Why?
| | Liver Cirrhosis | 2 | 2020 | 245 | 0.120 |
Why?
| | Colectomy | 1 | 2014 | 84 | 0.120 |
Why?
| | Multivariate Analysis | 4 | 2021 | 1474 | 0.120 |
Why?
| | Predictive Value of Tests | 6 | 2016 | 1868 | 0.120 |
Why?
| | Hemorrhage | 1 | 2018 | 623 | 0.120 |
Why?
| | Patient Safety | 1 | 2016 | 281 | 0.120 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2013 | 16 | 0.110 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2013 | 27 | 0.110 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 27 | 0.110 |
Why?
| | Exercise Therapy | 1 | 2016 | 355 | 0.110 |
Why?
| | Recurrence | 4 | 2020 | 975 | 0.110 |
Why?
| | Contrast Media | 1 | 1995 | 373 | 0.110 |
Why?
| | Community Health Services | 1 | 2014 | 212 | 0.110 |
Why?
| | Bile Duct Diseases | 1 | 2012 | 17 | 0.110 |
Why?
| | Ultrasonography, Interventional | 2 | 2015 | 155 | 0.110 |
Why?
| | Cholecystitis | 1 | 1992 | 17 | 0.110 |
Why?
| | Risk Assessment | 8 | 2016 | 3057 | 0.110 |
Why?
| | Health Care Costs | 1 | 2015 | 394 | 0.110 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1991 | 7 | 0.100 |
Why?
| | Lymph Nodes | 2 | 2012 | 455 | 0.100 |
Why?
| | Diverticulum | 1 | 1991 | 11 | 0.100 |
Why?
| | Duodenal Diseases | 1 | 1991 | 10 | 0.100 |
Why?
| | Digestive System Diseases | 1 | 2011 | 27 | 0.100 |
Why?
| | Diagnosis, Differential | 6 | 2015 | 1384 | 0.100 |
Why?
| | Sensation | 1 | 1991 | 43 | 0.100 |
Why?
| | Esophageal Diseases | 1 | 1991 | 26 | 0.100 |
Why?
| | Proteomics | 1 | 2017 | 876 | 0.100 |
Why?
| | Chest Pain | 1 | 1991 | 84 | 0.100 |
Why?
| | Time Factors | 8 | 2019 | 6412 | 0.100 |
Why?
| | United States | 10 | 2018 | 12555 | 0.100 |
Why?
| | Administration, Rectal | 2 | 2024 | 5 | 0.100 |
Why?
| | Patient Compliance | 1 | 2015 | 537 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2674 | 0.100 |
Why?
| | Deglutition | 1 | 1991 | 65 | 0.100 |
Why?
| | Hypotension | 1 | 2011 | 120 | 0.090 |
Why?
| | Muscle, Smooth | 1 | 1991 | 157 | 0.090 |
Why?
| | Disease Progression | 5 | 2017 | 2490 | 0.090 |
Why?
| | Hepatic Duct, Common | 1 | 2010 | 6 | 0.090 |
Why?
| | Colonoscopes | 1 | 2009 | 5 | 0.090 |
Why?
| | Bile | 1 | 2009 | 31 | 0.090 |
Why?
| | Image Enhancement | 1 | 2011 | 181 | 0.090 |
Why?
| | Cholecystostomy | 1 | 1989 | 4 | 0.090 |
Why?
| | Odds Ratio | 4 | 2016 | 996 | 0.090 |
Why?
| | Sleep Apnea Syndromes | 1 | 2010 | 80 | 0.090 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2010 | 74 | 0.090 |
Why?
| | Abdominal Neoplasms | 1 | 2009 | 28 | 0.090 |
Why?
| | Anesthetics | 1 | 2009 | 58 | 0.090 |
Why?
| | Loss of Heterozygosity | 1 | 2009 | 40 | 0.080 |
Why?
| | Tumor Burden | 3 | 2015 | 274 | 0.080 |
Why?
| | Equipment Safety | 2 | 2009 | 38 | 0.080 |
Why?
| | Mutation | 1 | 2019 | 3457 | 0.080 |
Why?
| | Intestinal Obstruction | 1 | 2009 | 41 | 0.080 |
Why?
| | DNA, Neoplasm | 1 | 2009 | 154 | 0.080 |
Why?
| | Cholangiography | 1 | 2008 | 20 | 0.080 |
Why?
| | Incidence | 5 | 2018 | 2424 | 0.080 |
Why?
| | Choledocholithiasis | 1 | 2008 | 14 | 0.080 |
Why?
| | Video Recording | 3 | 2014 | 156 | 0.080 |
Why?
| | Feeding Behavior | 1 | 2013 | 601 | 0.080 |
Why?
| | Quality Assurance, Health Care | 1 | 2010 | 325 | 0.080 |
Why?
| | Ultrasonography | 4 | 1996 | 716 | 0.080 |
Why?
| | Health Services Research | 1 | 2010 | 385 | 0.070 |
Why?
| | Acute Disease | 4 | 2008 | 940 | 0.070 |
Why?
| | Positron-Emission Tomography | 1 | 2008 | 298 | 0.070 |
Why?
| | Registries | 1 | 2015 | 1810 | 0.070 |
Why?
| | Biopsy, Needle | 2 | 2004 | 190 | 0.070 |
Why?
| | Delphi Technique | 2 | 2017 | 164 | 0.070 |
Why?
| | Prognosis | 5 | 2017 | 3443 | 0.070 |
Why?
| | Hyperplasia | 2 | 2019 | 170 | 0.070 |
Why?
| | Research Design | 2 | 2016 | 969 | 0.070 |
Why?
| | Pleural Diseases | 1 | 2006 | 21 | 0.070 |
Why?
| | Pancreatic Fistula | 1 | 2006 | 21 | 0.070 |
Why?
| | Adolescent | 7 | 2024 | 18480 | 0.070 |
Why?
| | Hypoxia | 1 | 2011 | 963 | 0.070 |
Why?
| | Pain | 2 | 2022 | 735 | 0.060 |
Why?
| | Surveys and Questionnaires | 4 | 2015 | 4708 | 0.060 |
Why?
| | Cohort Studies | 5 | 2020 | 5116 | 0.060 |
Why?
| | Hospital Units | 1 | 2004 | 24 | 0.060 |
Why?
| | Tertiary Care Centers | 2 | 2016 | 119 | 0.060 |
Why?
| | Health Care Surveys | 3 | 2014 | 546 | 0.060 |
Why?
| | Cyst Fluid | 2 | 2018 | 27 | 0.060 |
Why?
| | Diphenhydramine | 1 | 2023 | 29 | 0.060 |
Why?
| | Midazolam | 1 | 2023 | 49 | 0.060 |
Why?
| | Efficiency, Organizational | 1 | 2004 | 126 | 0.060 |
Why?
| | Disposable Equipment | 2 | 2009 | 15 | 0.060 |
Why?
| | Observer Variation | 2 | 2014 | 309 | 0.060 |
Why?
| | Missouri | 2 | 2014 | 63 | 0.060 |
Why?
| | Fentanyl | 1 | 2023 | 70 | 0.060 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 610 | 0.060 |
Why?
| | Mass Screening | 1 | 2010 | 1052 | 0.060 |
Why?
| | Electrocoagulation | 1 | 2023 | 36 | 0.060 |
Why?
| | Animals | 3 | 2020 | 33381 | 0.050 |
Why?
| | Neoplasms | 1 | 2016 | 2179 | 0.050 |
Why?
| | Hypnotics and Sedatives | 1 | 2023 | 136 | 0.050 |
Why?
| | Necrosis | 1 | 2023 | 230 | 0.050 |
Why?
| | Esophagitis, Peptic | 1 | 2002 | 18 | 0.050 |
Why?
| | Guidelines as Topic | 2 | 2015 | 262 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 3 | 2006 | 2436 | 0.050 |
Why?
| | Endoscopes | 2 | 1998 | 19 | 0.050 |
Why?
| | Hyperthermia, Induced | 1 | 2002 | 67 | 0.050 |
Why?
| | Cholestasis, Intrahepatic | 1 | 2001 | 43 | 0.050 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2001 | 53 | 0.050 |
Why?
| | Length of Stay | 4 | 2018 | 1032 | 0.050 |
Why?
| | Lumbar Vertebrae | 1 | 2023 | 215 | 0.050 |
Why?
| | Feasibility Studies | 2 | 2018 | 749 | 0.050 |
Why?
| | Silicones | 1 | 2020 | 21 | 0.050 |
Why?
| | Hemostatic Techniques | 1 | 2000 | 40 | 0.050 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2000 | 39 | 0.050 |
Why?
| | Los Angeles | 1 | 2020 | 60 | 0.050 |
Why?
| | Combined Modality Therapy | 2 | 2016 | 1166 | 0.050 |
Why?
| | Technology Assessment, Biomedical | 5 | 1998 | 29 | 0.040 |
Why?
| | Contraindications | 2 | 2017 | 86 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 56 | 0.040 |
Why?
| | Equivalence Trials as Topic | 1 | 2019 | 6 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2020 | 314 | 0.040 |
Why?
| | General Surgery | 1 | 2000 | 134 | 0.040 |
Why?
| | Clinical Trials as Topic | 2 | 2015 | 969 | 0.040 |
Why?
| | Adenocarcinoma, Mucinous | 2 | 2009 | 59 | 0.040 |
Why?
| | Electrodes | 1 | 1998 | 89 | 0.040 |
Why?
| | Probability | 2 | 2009 | 305 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2006 | 1185 | 0.040 |
Why?
| | Electrosurgery | 1 | 1998 | 45 | 0.040 |
Why?
| | Practice Patterns, Physicians' | 3 | 2014 | 1200 | 0.040 |
Why?
| | Resuscitation | 1 | 2000 | 253 | 0.040 |
Why?
| | Swine | 1 | 2020 | 730 | 0.040 |
Why?
| | Reference Standards | 1 | 2018 | 176 | 0.040 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2018 | 75 | 0.040 |
Why?
| | Surgical Instruments | 1 | 2018 | 49 | 0.040 |
Why?
| | Statistics, Nonparametric | 2 | 2008 | 403 | 0.040 |
Why?
| | Granulation Tissue | 1 | 2016 | 6 | 0.040 |
Why?
| | Radiology | 1 | 2000 | 199 | 0.040 |
Why?
| | Manometry | 2 | 2001 | 89 | 0.040 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2008 | 158 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 252 | 0.040 |
Why?
| | Organizational Policy | 1 | 2017 | 70 | 0.040 |
Why?
| | Patient Admission | 1 | 2018 | 176 | 0.040 |
Why?
| | Gastric Fistula | 1 | 1996 | 4 | 0.040 |
Why?
| | Prevalence | 2 | 2015 | 2326 | 0.040 |
Why?
| | Surgery, Computer-Assisted | 1 | 2017 | 69 | 0.040 |
Why?
| | Neoplasm Seeding | 1 | 1996 | 8 | 0.040 |
Why?
| | Cystic Duct | 1 | 1996 | 4 | 0.040 |
Why?
| | Fasciitis, Necrotizing | 1 | 1996 | 9 | 0.040 |
Why?
| | Intestinal Fistula | 1 | 1996 | 12 | 0.040 |
Why?
| | Tissue Banks | 1 | 2016 | 19 | 0.040 |
Why?
| | Cutaneous Fistula | 1 | 1996 | 13 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2015 | 2513 | 0.030 |
Why?
| | Survival Rate | 1 | 2000 | 1720 | 0.030 |
Why?
| | Foreign-Body Migration | 1 | 1996 | 37 | 0.030 |
Why?
| | Diatrizoate Meglumine | 1 | 1995 | 3 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 9491 | 0.030 |
Why?
| | Iopamidol | 1 | 1995 | 13 | 0.030 |
Why?
| | Digestive System | 1 | 1995 | 30 | 0.030 |
Why?
| | Weight Reduction Programs | 1 | 2017 | 93 | 0.030 |
Why?
| | Patient Care Team | 1 | 2000 | 521 | 0.030 |
Why?
| | Decision Trees | 1 | 2015 | 83 | 0.030 |
Why?
| | Image-Guided Biopsy | 1 | 2015 | 34 | 0.030 |
Why?
| | Peritonitis | 1 | 1996 | 79 | 0.030 |
Why?
| | Quality-Adjusted Life Years | 1 | 2015 | 103 | 0.030 |
Why?
| | Netherlands | 1 | 2015 | 62 | 0.030 |
Why?
| | Markov Chains | 1 | 2015 | 118 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 1995 | 185 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2017 | 237 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 829 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 3174 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2015 | 202 | 0.030 |
Why?
| | Consensus | 1 | 2017 | 534 | 0.030 |
Why?
| | Lipids | 1 | 2018 | 607 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2016 | 238 | 0.030 |
Why?
| | Incidental Findings | 1 | 2015 | 80 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2015 | 324 | 0.030 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2014 | 79 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 1995 | 170 | 0.030 |
Why?
| | Advisory Committees | 1 | 2015 | 212 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2018 | 635 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 473 | 0.030 |
Why?
| | Patient Participation | 1 | 2017 | 369 | 0.030 |
Why?
| | Medicaid | 1 | 2017 | 411 | 0.030 |
Why?
| | Health Status Indicators | 1 | 2014 | 154 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 1995 | 272 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1129 | 0.030 |
Why?
| | Patient Selection | 1 | 2017 | 676 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 554 | 0.030 |
Why?
| | Program Evaluation | 1 | 2017 | 845 | 0.030 |
Why?
| | Palliative Care | 1 | 2019 | 629 | 0.030 |
Why?
| | Sphincter of Oddi | 1 | 2012 | 4 | 0.030 |
Why?
| | Radio Waves | 2 | 2003 | 16 | 0.030 |
Why?
| | Colic | 1 | 1992 | 6 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 693 | 0.030 |
Why?
| | Mediastinum | 1 | 2012 | 21 | 0.030 |
Why?
| | Mucous Membrane | 1 | 2013 | 113 | 0.030 |
Why?
| | Esophagitis | 1 | 2013 | 66 | 0.030 |
Why?
| | Adenoma, Villous | 1 | 2012 | 2 | 0.030 |
Why?
| | Medicare | 1 | 2017 | 663 | 0.030 |
Why?
| | Decision Support Techniques | 1 | 2015 | 364 | 0.030 |
Why?
| | Anesthetics, Intravenous | 1 | 2011 | 34 | 0.030 |
Why?
| | Blood Pressure | 1 | 2018 | 1664 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2011 | 210 | 0.030 |
Why?
| | Heartburn | 2 | 2001 | 11 | 0.030 |
Why?
| | Edema | 1 | 2011 | 124 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 10 | 0.020 |
Why?
| | Body Height | 1 | 1991 | 187 | 0.020 |
Why?
| | Preoperative Care | 1 | 1992 | 332 | 0.020 |
Why?
| | Gastroscopes | 1 | 2010 | 3 | 0.020 |
Why?
| | Esophageal pH Monitoring | 1 | 2010 | 23 | 0.020 |
Why?
| | Epithelium | 1 | 2011 | 305 | 0.020 |
Why?
| | Duodenoscopy | 1 | 2009 | 7 | 0.020 |
Why?
| | Methods | 1 | 1989 | 67 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1153 | 0.020 |
Why?
| | Punctures | 1 | 1989 | 39 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2001 | 536 | 0.020 |
Why?
| | Reference Values | 1 | 1991 | 774 | 0.020 |
Why?
| | Injections | 1 | 2010 | 167 | 0.020 |
Why?
| | Radiography | 1 | 1992 | 861 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 1991 | 499 | 0.020 |
Why?
| | Adenocarcinoma, Papillary | 1 | 2009 | 9 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2009 | 64 | 0.020 |
Why?
| | Light | 1 | 2011 | 342 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 842 | 0.020 |
Why?
| | Age Distribution | 1 | 2009 | 362 | 0.020 |
Why?
| | Sex Distribution | 1 | 2009 | 351 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 1991 | 261 | 0.020 |
Why?
| | ras Proteins | 1 | 2009 | 141 | 0.020 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2008 | 131 | 0.020 |
Why?
| | Muscle Contraction | 1 | 1991 | 413 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 237 | 0.020 |
Why?
| | Specimen Handling | 1 | 2009 | 165 | 0.020 |
Why?
| | Radiopharmaceuticals | 1 | 2008 | 194 | 0.020 |
Why?
| | Age Factors | 1 | 2015 | 2995 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 809 | 0.020 |
Why?
| | Intraoperative Complications | 1 | 2008 | 132 | 0.020 |
Why?
| | Exercise | 1 | 2017 | 1657 | 0.020 |
Why?
| | Safety Management | 1 | 2007 | 109 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2008 | 230 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2009 | 317 | 0.020 |
Why?
| | Thoracic Surgery | 1 | 2008 | 120 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2008 | 4552 | 0.020 |
Why?
| | Survival Analysis | 1 | 2009 | 1267 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2008 | 1293 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2009 | 618 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1691 | 0.020 |
Why?
| | Infant | 1 | 2018 | 8293 | 0.020 |
Why?
| | Child | 2 | 2018 | 19129 | 0.020 |
Why?
| | Comorbidity | 1 | 2009 | 1527 | 0.020 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2004 | 81 | 0.020 |
Why?
| | Sex Factors | 1 | 2009 | 1781 | 0.010 |
Why?
| | False Negative Reactions | 1 | 2002 | 57 | 0.010 |
Why?
| | Reoperation | 2 | 1996 | 557 | 0.010 |
Why?
| | Gastric Acidity Determination | 1 | 2002 | 7 | 0.010 |
Why?
| | Attitude of Health Personnel | 1 | 2009 | 992 | 0.010 |
Why?
| | Cholangiocarcinoma | 1 | 2001 | 38 | 0.010 |
Why?
| | Energy Transfer | 1 | 2001 | 52 | 0.010 |
Why?
| | Computer Simulation | 1 | 2004 | 922 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 114 | 0.010 |
Why?
| | Safety | 1 | 1998 | 304 | 0.010 |
Why?
| | Radiology, Interventional | 1 | 1996 | 28 | 0.010 |
Why?
| | Oximetry | 1 | 1995 | 84 | 0.010 |
Why?
| | Blood Pressure Determination | 1 | 1995 | 133 | 0.010 |
Why?
| | Technetium Tc 99m Disofenin | 1 | 1992 | 3 | 0.010 |
Why?
| | Sincalide | 1 | 1992 | 5 | 0.010 |
Why?
| | Imino Acids | 1 | 1992 | 5 | 0.010 |
Why?
| | Gallbladder | 1 | 1992 | 15 | 0.010 |
Why?
| | Electrocardiography | 1 | 1995 | 556 | 0.010 |
Why?
| | Organotechnetium Compounds | 1 | 1992 | 17 | 0.010 |
Why?
| | Radionuclide Imaging | 1 | 1992 | 124 | 0.010 |
Why?
| | Aniline Compounds | 1 | 1992 | 71 | 0.010 |
Why?
| | Glycine | 1 | 1992 | 162 | 0.010 |
Why?
| | Chronic Disease | 1 | 1995 | 1636 | 0.010 |
Why?
| | Pregnancy | 1 | 2001 | 5691 | 0.010 |
Why?
|
|
Edmundowicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|